Hiu Yee KWAN – Research Output — Hong Kong Baptist University

Hiu Yee KWAN public CV

View Scopus Profile

Emailhykwanhkbu.eduhk

Accepting PhD Students

PhD projects

To develop sEVs based therapeutic approach for cancer and obesity treatments.

Research activity per year

If you made any changes in Pure these will be visible here soon.

103 Journal article
10 Review article
2 Letter
1 Editorial

2 results

Filter

2021

Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer
Chen, M., Zhong, K., Tan, J., Meng, M. M., Liu, C. M., Chen, B., Huang, C., Wong, H. L. X., Bian, Z., Su, T. & Kwan, H. Y., Nov 2021, In: Clinical and Translational Medicine. 11, 11, e564.
Research output: Contribution to journal › Letter › peer-review

Open Access
2014
Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II
FU, X., Chou, G. X., KWAN, H. Y., TSE, A. K. W., Zhao, L. H., Yuen, T. K., Cao, H. H., Yu, H., Chao, X. J., Su, T., Cheng, B. C. Y., Sun, X. G. & YU, Z., 1 Nov 2014, In: Experimental Dermatology. 23, 11, p. 855-857 3 p.
Research output: Contribution to journal › Letter › peer-review

Open Access
28 Citations (Scopus)